Biosynthesis and photodynamic efficacy of protoporphyrin IX (PpIX) generated by 5-aminolevulinic acid (ALA) or its hexylester (hALA) in rat bladder carcinoma cells

J Photochem Photobiol B. 2000 Dec;59(1-3):72-9. doi: 10.1016/s1011-1344(00)00142-1.

Abstract

Hexylester of 5-aminolevulinic acid (hALA) has been considered as an alternative to 5-aminolevulinic acid (ALA) for the treatment of malignancies of different origin. The present study addresses the ALA and hALA-induced PpIX pharmacokinetic profile using rat bladder carcinoma cells (AY27). The total PpIX content measured spectrofluorimetrically after extraction procedure at the end of 2 h incubation was at least 1.5-fold greater with hALA compared to ALA despite the difference in concentration of several orders between the two compounds (1 or 5 mM ALA and 5 or 10 x 10(-3) mM hALA). Considerable PpIX efflux was detected in the extracellular medium at the end of the incubation. With 5 mM ALA and 10 x 10(-3) mM hALA, PpIX build-up was continued beyond the incubation period pointing out to enzyme saturation in the biosynthetic pathway or/and the constitution of ALA reserve. Red laser light (lambda=630 nm) irradiation of AY27 cells after 2 h incubation with increasing ALA or hALA concentrations resulted in a nearly equal photocytotoxicity.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aminolevulinic Acid / pharmacology*
  • Animals
  • Cell Extracts
  • Cell Survival
  • Culture Media
  • Culture Media, Serum-Free
  • Dose-Response Relationship, Drug
  • Fluorescence
  • Photochemotherapy* / methods
  • Photosensitizing Agents / pharmacokinetics
  • Photosensitizing Agents / pharmacology*
  • Protoporphyrins / biosynthesis
  • Protoporphyrins / pharmacokinetics
  • Protoporphyrins / pharmacology*
  • Rats
  • Tumor Cells, Cultured
  • Urinary Bladder Neoplasms / drug therapy*

Substances

  • Cell Extracts
  • Culture Media
  • Culture Media, Serum-Free
  • Photosensitizing Agents
  • Protoporphyrins
  • Aminolevulinic Acid
  • protoporphyrin IX